Glaxosmithkline Share News (GSK)

GSK's beats on revenues but guidance fails to impress - UPDATE

GlaxoSmithKline (GSK) saw improved turnover in the fourth quarter as the drugmaker expanded its portfolio and launched new products, but its full year guidance failed to impress. Turnover edged up 2% to £6.9bn in the last three months of 2013, surprising analysts who had expected a turnover of £6.

GlaxoSmithKline signals better 2014 as drug R&D improves

LONDON, Feb 5 (Reuters) - GlaxoSmithKline flagged a pick-up in growth this year as productivity in its drug research labs improves and pressure on sales in China moderates following a damaging bribery scandal in the country. Britain's biggest drugmaker said on Wednesday it expected 2014 sal

TOP NEWS: London Commuters Take To The Streets Amid Tube Strike

LONDON (Alliance News) - The following is a summary of top news stories Wednesday.
----------
COMPANIES
----------
Hargreaves Lansdown PLC reported record pretax profit and revenue for the half year, as it continues to add new clients amid

MARKET COMMENT: FTSE 100 Set To Extend Losses Ahead Of Data

LONDON (Alliance News) - UK equities are set for yet another negative start Wednesday as investors await a raft of macro-economic data from the UK, the US, and Europe and despite a higher close on Wall Street overnight. Meanwhile, some London-based traders may be struggling to get to their

London pre-open: FTSE to open lower despite US and Asia gains

City sources predict the FTSE 100 will open 20 points below yesterday's close of 6,449.27, ignoring decent gains seen in both the US and Asia overnight. Upbeat corporate earnings and a bout of bargain hunting helped US markets put in decent gains on Tuesday as stocks recovered from their worst sell

UK Earnings, Trading Statements Calendar - Week Ahead

Read more 4 Feb 2014 17:39 MARKET COMMENT: FTSE 100 Closes Lower For Fifth Straight Day LONDON (Alliance News) - The FTSE 100 closed lower for a fifth consecutive day Tuesday, even though the index was higher at one point, as concerns about the impact of the Federal Reserve's tapering of its economic stimulus programme continued to weigh on stock markets across the world. Read more 4 Feb 2014 16:27 EARNINGS PREVIEW: AstraZeneca Set To Swing To Loss, Glaxo Flatlines LONDON (Alliance News) - The UK's two largest pharmaceuticals companies will report 2013 earnings this week, with AstraZeneca expected to show a fourth quarter loss when it reports Thursday, while GlaxoSmithKline profits are expected to have flatlined over the year as a whole. Both companie Read more 4 Feb 2014 16:06 UK Earnings, Trading Statements Calendar - Week Ahead Read more 4 Feb 2014 12:25 RPT-Fitch: EMEA Corporates' Sector Earnings Expectations Feb 4 (Reuters) - (The following statement was released by the rating agency) Fitch Ratings expects EMEA corporates' FY13 financial results to have generally underperformed company guidance and prior year results, driven by challenging market conditions in early 2013, delayed benefits of th Read more 4 Feb 2014 07:34 Ten rivals join with NIH to search for new drugs - WSJ Feb 4 (Reuters) - Ten big rival drug companies have formed a pact to cooperate on a government-backed effort to accelerate the discovery of new drugs, the Wall Street Journal reported. The companies and the National Institutes of Health (NIH) will share scientists, tissue and blood samples, Read more 4 Feb 2014 06:11 UK Earnings, Trading Statements Calendar - Week Ahead Read more 3 Feb 2014 16:21 DIRECTOR DEALINGS: Glaxo Executive Diretor Alloctaed ADSs LONDON (Alliance News) - LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said Executive Director Moncef Slaoui was allocated 17 American Depositary Shares at a price of USD51.54 each Friday. Glaxo shares were up 0.8% at 1,576.50 pence Monday. B Read more 3 Feb 2014 16:19 UK Earnings, Trading Statements Calendar - Week Ahead Read more 3 Feb 2014 13:46 UK MIDDAY BRIEFING: Mis-Selling Bill Continues To Mount For UK Banks LONDON (Alliance News) - UK banks are still counting the cost of their product mis-selling, with Lloyds Banking Group Monday adding a further GBP1.93 billion to the amount it has set aside to cover claims for previous sales of payment protection insurance and interest rate hedging products. Read more 287288289290291292293294295 Stay Informed! With our newsletters and social media channels. Daily Market Report (Weekday Evenings)Week Ahead (Sunday Evening) Login to your account Login failed Remember MeSign In Don't have an account? Click here to register. Quickpicks are a member only feature Login to your account Login failed Remember MeSign In Don't have an account? Click here to register.